Trial Profile
Multicentre, double-blind, randomised, placebo-controlled phase Ib multiple dose study to evaluate the tolerability and pharmacokinetics of AEOL 10150 in patients with amyotrophic lateral sclerosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs AEOL 10150 (Primary)
- Indications Amyotrophic lateral sclerosis
- Focus Adverse reactions; Pharmacokinetics
- 05 Nov 2010 New trial record.